Automated Cell Shakers Market Size & Growth Forecast 2027–2036, By Segments (Application, End-use, Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 23413| Published Date: Nov-2026| Format: PDF, Excel
Jump to Content
Market Outlook

Market Size and Growth Outlook

Automated Cell Shakers Market size stood at USD 785.8 million in 2026 and is predicted to grow at a 7.53% CAGR from 2027 to 2036, attaining USD 1.62 billion by 2036. The industry revenue for 2027 is estimated at USD 836.01 million.

Base Year Value (2026)
USD 785.8 million
CAGR (2027-2036)
7.53%
Forecast Year Value (2036)
USD 1.62 billion
Historical Data Period
2022-2026
Largest Region
North America
Forecast Period
2027-2036

Get more details on this report

Request Free Sample Report
Snapshot

Automated Cell Shakers Market Intelligence Snapshot

Regional Market Dynamics

  • North America leads through advanced life sciences infrastructure, strong research activity, and laboratory automation investments supporting consistent workflows across drug discovery, cell culture, and bioprocessing.
  • Expanding biotechnology research, pharmaceutical manufacturing, and laboratory modernization are increasing demand for automated systems that improve throughput, reproducibility, and operational efficiency.

Segment Momentum

  • Drug development held a 40.83% market share in 2026, reflecting the need for controlled agitation, reproducible cell culture conditions, and reduced manual intervention across pharmaceutical research and development workflows.
  • Regenerative medicine is growing fastest as cell-based therapies and tissue engineering require consistent cell expansion and controlled processing. Automated shakers support reproducibility, reduce manual variability, and improve laboratory workflow efficiency.

Market Expansion Drivers

  • Adoption of automated lab equipment in biotech.
  • Integration with high-throughput screening platforms.
  • Growth of contract research organizations (CROs) in emerging regions.

Leading Market Participants

  • Major players in the automated cell shakers market include Thermo Fisher Scientific (USA), Eppendorf (Germany), Sartorius (Germany), INFORS HT (Switzerland), Kuhner Shaker (Switzerland), Benchmark Scientific (USA), Sheldon Manufacturing (USA), Jeio Tech (South Korea), Grant Instruments (UK), Major Science (Taiwan).

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 785.8 million
  • 2027 Estimated Market Size: USD 836.01 million
  • Projected Market Size: USD 1.62 billion by 2036
  • Growth Forecast: 7.53% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Application (Drug Development) | End-use (Pharmaceutical Companies) | Product (Automated Cell Shakers)
  • Emerging Opportunity Segment: Application (Regenerative Medicine) | End-use (Pharmaceutical Companies) | Product (Automated Cell Shakers)
Market Dynamics

Market Growth Drivers and Industry Trends

Adoption of Automated Laboratory Equipment in Biotechnology

Growing adoption of automated laboratory equipment across biotechnology research is driving demand for automated cell shakers that can provide consistent agitation, controlled operating conditions, and improved process reproducibility. These systems help laboratories streamline cell culture, microbial growth, sample preparation, and other repetitive workflows while reducing manual intervention and operator variability. Increasing emphasis on laboratory productivity, process standardization, and scalable research workflows is supporting broader integration of automated cell shaking technologies across biotechnology applications.

Integration with High-Throughput Screening Platforms

Integration of automated cell shakers with high-throughput screening platforms is creating demand for equipment capable of handling larger sample volumes with greater consistency and process coordination. Automated shaking systems can support precise mixing and incubation requirements within complex laboratory workflows, enabling smoother integration with robotic handling, screening, and analytical platforms. Rising demand for accelerated drug discovery, biological testing, and automated experimental workflows is therefore encouraging laboratories to adopt increasingly interconnected cell shaking solutions.

Expansion of Contract Research Organizations in Emerging Regions

The expansion of contract research organizations across emerging regions is increasing demand for automated laboratory systems that can support growing research workloads and standardized testing processes. These organizations require reliable equipment capable of improving throughput, reproducibility, and operational efficiency across biotechnology, pharmaceutical, and life science research activities. Increasing outsourcing of research and development functions, combined with investments in laboratory infrastructure, is supporting wider adoption of automated cell shakers in developing research markets.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Adoption of automated lab equipment in biotech 2% Short term (≤ 2 yrs) North America; Europe; spillover: Asia Pacific Medium Fast
Integration with high-throughput screening platforms 1.5% Medium term (2–5 yrs) Europe; North America; spillover: Asia Pacific Low Moderate
Growth of contract research organizations (CROs) in emerging regions 1% Long term (5+ yrs) Asia Pacific; Latin America; spillover: MEA Low Slow

Explore Growth Opportunities

Request Free Sample Report
Regional Forecast

Regional Demand Dynamics

Automated Cell Shakers Market
Largest Region
North America
XX% Market Share in 2026

North America (Largest Region)

North America held the largest share of the automated cell shakers market in 2026, supported by advanced life sciences infrastructure, strong research activity, and increasing adoption of automated laboratory technologies. Pharmaceutical and biotechnology organizations are increasingly using automated cell handling and shaking systems to improve workflow consistency, reduce manual intervention, and support high-throughput research. The expansion of cell-based research, drug discovery, bioprocessing, and laboratory automation is creating sustained demand for sophisticated equipment capable of maintaining controlled operating conditions. Growing emphasis on reproducibility, productivity, and process standardization is also encouraging laboratories to replace manual procedures with automated systems. In addition, continued investments in research facilities and advanced biomanufacturing capabilities are strengthening the adoption of automated cell shakers across the region.

Asia Pacific (Fastest-Growing Region)

Asia Pacific is the fastest-growing region in the automated cell shakers market, driven by expanding pharmaceutical and biotechnology industries, increasing research activities, and growing investments in laboratory automation. Countries across the region are strengthening their life sciences capabilities and developing advanced research infrastructure to support drug discovery, cell culture, and bioprocessing applications. The increasing adoption of automated laboratory workflows is helping organizations improve productivity, consistency, and operational efficiency while reducing dependence on manual processes. Rising investments in biotechnology research, expansion of pharmaceutical manufacturing, and growing demand for high-throughput laboratory systems are further supporting market development. Increasing modernization of research facilities and broader adoption of advanced laboratory technologies are expected to create additional opportunities for automated cell shaker solutions across the region.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation HubiScaleNascentDeveloping Advanced
Cost-Sensitive RegioniScaleLowMedium High
Regulatory EnvironmentiScaleRestrictiveNeutral Supportive
Demand DriversiScaleWeakModerate Strong
Development StageiScaleEmergingDeveloping Developed
Adoption RateiScaleLowMedium High
New Entrants / StartupsiScaleSparseModerate Dense
Macro IndicatorsiScaleWeakStable Strong
🔒 Need data on a specific country or region? Individual country/region reports are available at discounted pricing. Inquire Before Buying
COUNTRY INSIGHTS

Key Country Insights

United States 🇺🇸

High-Throughput Cell Processing

The U.S. automated cell shakers market emphasizes reproducible, high-throughput sample processing across biotechnology, pharmaceutical, and research laboratories. Buyers prioritize programmable motion, precise environmental control, automation compatibility, and reliable operation that can support standardized workflows while reducing manual handling and variability.

Germany 🇩🇪

Precision Laboratory Automation

Germany’s automated cell shakers market prioritizes precision, process consistency, and integration with sophisticated laboratory automation. Demand centers on equipment capable of controlled agitation, reproducible protocols, low-maintenance operation, and compatibility with research and bioprocessing workflows where reliable sample handling is essential.

Japan 🇯🇵

Compact Workflow Automation

Japan’s automated cell shakers market favors compact, reliable systems that fit efficiently into space-constrained laboratory environments. Product priorities include quiet operation, precise shaking control, programmable protocols, and compatibility with automated sample-processing workflows used across pharmaceutical, biotechnology, and academic research settings.

South Korea 🇰🇷

Automated Bioprocess Handling

South Korea’s automated cell shakers market is supported by biotechnology, pharmaceutical, and advanced research applications requiring repeatable sample preparation. Equipment priorities include programmable operation, high process consistency, automation interfaces, and scalable configurations that can support increasingly integrated laboratory and bioprocessing environments.

France 🇫🇷

Reproducible Research Automation

France’s automated cell shakers market centers on reproducibility and controlled laboratory workflows across life sciences research and biopharmaceutical applications. Users value programmable shaking profiles, dependable temperature and motion control, and automation compatibility that can reduce manual intervention while supporting standardized experimental protocols.

Italy 🇮🇹

Flexible Lab Processing

Italy’s automated cell shakers market serves research and laboratory environments where flexible equipment configurations can support varied sample-processing requirements. Commercial priorities include programmable controls, dependable agitation, straightforward operation, and compatibility with laboratory automation systems, particularly for biotechnology and pharmaceutical workflows.

Automated Cell Shakers Market Share (%), by Application, 2026

40.83%
Drug Development
Regenerative Medicine
Stem Cell Research
Cell Therapy

Go beyond the chart, access full insights & data tables

Request Free Sample Report

Application Segment Analysis: Drug Development (Largest Segment) vs Regenerative Medicine (Fastest-Growing Segment)

The drug development segment accounted for a 40.83% share of the automated cell shakers market in 2026, supported by the extensive use of controlled cell culture and mixing processes throughout pharmaceutical research and development. Automated cell shakers help maintain consistent agitation, aeration, and environmental conditions required for cell growth, sample preparation, and laboratory experimentation. Their ability to provide repeatable operating conditions and reduce manual intervention is particularly valuable in drug discovery and development workflows, where reproducibility and process control are essential. Increasing pharmaceutical research activity and the growing complexity of cell-based experimentation are encouraging laboratories to adopt automated equipment that can improve workflow efficiency and support standardized experimental protocols. Integration with automated laboratory systems and increasingly sophisticated cell culture workflows is further strengthening the role of automated cell shakers in drug development applications.

The regenerative medicine segment is expected to grow at the fastest pace in the automated cell shakers market, driven by increasing research into cell-based therapies, tissue engineering, and advanced regenerative approaches. These applications require controlled and reproducible cell expansion environments to support the development of viable cell populations and biological constructs. Automated cell shakers can facilitate consistent mixing and environmental control while reducing variability associated with manual laboratory operations. The growing emphasis on scalable cell-processing workflows is also increasing demand for equipment capable of supporting more standardized and efficient experimental processes. As regenerative medicine research advances toward more sophisticated cell culture and therapeutic development applications, the need for reliable automation, reproducibility, and controlled processing is expected to support rapid adoption of automated cell shakers in this segment.

End-use Segment Analysis: Pharmaceutical Companies (Largest & Fastest-Growing Segment)

The pharmaceutical companies segment accounted for a 41.53% share of the automated cell shakers market in 2026 and represents both the largest and fastest-growing end-use segment, reflecting the extensive role of automated cell culture equipment in pharmaceutical research, development, and process optimization. Pharmaceutical companies use automated cell shakers across laboratory workflows involving cell growth, formulation research, screening, biological studies, and development of advanced therapeutics. Automation helps improve consistency, reduce manual handling, and support reproducible experimental conditions, which are important for research environments operating across multiple development stages. Increasing investment in biologics, cell-based research, and complex therapeutic platforms is further broadening the need for controlled laboratory automation. At the same time, integration with digital laboratory workflows and scalable research processes is encouraging pharmaceutical organizations to modernize conventional cell culture practices, supporting sustained demand for automated cell shakers.

Product Segment Analysis: Automated Cell Shakers (Largest & Fastest-Growing Segment)

The automated cell shakers segment accounted for a 39.79% share of the automated cell shakers market in 2026 and is both the largest and fastest-growing product segment, reflecting the growing preference for laboratory equipment that can deliver consistent and programmable cell culture conditions. Automated cell shakers provide controlled agitation and mixing while minimizing repetitive manual tasks, making them suitable for research environments where process consistency and reproducibility are critical. Their application across pharmaceutical research, biotechnology workflows, cell-based studies, and other laboratory processes is expanding as researchers increasingly seek greater efficiency and standardized operating conditions. Advances in automation, digital controls, monitoring capabilities, and integration with broader laboratory systems are further improving equipment functionality. The growing adoption of automated laboratory workflows and the increasing complexity of cell-based experimentation are expected to reinforce demand for automated cell shakers across research and development environments.

Segment Sub-Segment Largest Segment Fastest Growing
Application Drug Development, Regenerative Medicine, Cell Therapy, Stem Cell Research Drug Development Regenerative Medicine
End-use Pharmaceutical Companies, Biopharmaceutical Companies, CDMOs & CMOs, Hospitals, Others Pharmaceutical Companies Pharmaceutical Companies
Product Automated Cell Shakers, Orbital Shakers, Benchtop Incubator Shakers, Cell Shaker with Rotatory Arms, Accessories, Others Automated Cell Shakers Automated Cell Shakers
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Competitive Landscape

Competitive Landscape and Market Positioning

Analyst Perspective:

Equipment performance relies heavily on balancing multi-axis motion control with precise agitation to ensure oxygen transfer and cell viability across diverse vessel formats. However, high mechanical accuracy provides limited value without robust environmental chamber integration, accurate sensor monitoring, and stable climate controls that prevent experimental variability. To support high-throughput workflows without expanding physical footprints, vendors differentiate through adaptable platforms and seamless LIMS connectivity that reduce manual entry and ensure data traceability. Ultimately, long-term market adoption hinges on providing repeatable protocol execution, simple cleaning procedures, and software integration that easily adapts as research validation requirements evolve.

Major players in the automated cell shakers market:

  1. Thermo Fisher Scientific (USA)
  2. Eppendorf (Germany)
  3. Sartorius (Germany)
  4. INFORS HT (Switzerland)
  5. Kuhner Shaker (Switzerland)
  6. Benchmark Scientific (USA)
  7. Sheldon Manufacturing (USA)
  8. Jeio Tech (South Korea)
  9. Grant Instruments (UK)
  10. Major Science (Taiwan)

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
Thermo Fisher Scientific (USA)
Eppendorf (Germany)
Sartorius (Germany)
INFORS HT (Switzerland)
Kuhner Shaker (Switzerland)
Benchmark Scientific (USA)
Sheldon Manufacturing (USA)
Jeio Tech (South Korea)
Grant Instruments (UK)
Major Science (Taiwan)
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
INDUSTRY NEWS

Industry Development/News

Company Name Date Key Development
Caron Scientific, Inc. March 2025 Caron Scientific, Inc. introduced the 7406 Incubator Shaker, engineered to deliver maximum single-chamber capacity within a compact footprint for cell culture environments. The system incorporates advanced contamination-control technology and optimized spatial efficiency, supporting biologics production and high-demand cell culture applications.
Kuhner Shaker January 2025 Kuhner Shaker launched the MPS-Z Automated, a specialized microtiter plate shaker configured for continuous, 24/7 cell culture handling. The unit integrates incubator-shaker technology with robotic automation capabilities to enhance process efficiency, reproducibility, and high-throughput operational workflows.
Wiggens Co. Ltd July 2023 Wiggens Co. Ltd commercialized the Celshak, a compact shaker engineered specifically for integration within CO2 incubators utilizing a non-belt magnetic drive mechanism. Constructed from stainless steel, the system features a physically separated controller to optimize durability and operational reliability in specialized laboratory environments.
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Automated Cell Shakers Market — Custom Segments

Segment Sub-Segment
Culture Volume Small-Scale, Mid-Scale, Large-Scale
Automation Connectivity Standalone Systems, Laboratory Information Management System (LIMS)-Connected, Fully Integrated Automation Systems
Purchase Model Direct Equipment Purchase, Equipment Leasing, Equipment-as-a-Service

Automated Cell Shakers Market — Custom TOC

Custom Chapter Chapter Details
Bioprocess Automation Adoption Landscape
  • Automation Penetration Across Bioprocess Workflows
  • Adoption Drivers in Research and Production Environments
  • Integration with Automated Laboratory Infrastructure
  • Capacity Expansion and Workflow Standardization Trends
  • Adoption Barriers and Investment Priorities
Application-Specific Shaking Platform Requirements
  • Shaking Requirements Across Cell Culture and Bioprocess Applications
  • Throughput, Temperature, and Environmental Control Needs
  • Platform Configuration and Automation Requirements
  • Application-Specific Selection Criteria
Consumables and Accessory Revenue Potential
  • Recurring Revenue Opportunities Across Shaking Workflows
  • Vessel, Plate, Flask, and Platform Compatibility
  • Accessory Attachments and Workflow-Enhancement Products
  • Consumable Adoption Drivers and Customer Lock-In
  • Expansion Opportunities Across Installed Equipment Bases

Need a different cut of the data?

Request Custom Research
FAQ

Frequently Asked Questions

What is the estimated worth of the automated cell shakers market?

In 2027, the market for automated cell shakers is worth approximately USD 836.01 million.

What is the projected value of the automated cell shakers industry by 2036?

Automated Cell Shakers Market size stood at USD 785.8 million in 2026 and is predicted to grow at a 7.53% CAGR from 2027 to 2036, attaining USD 1.62 billion by 2036.

How is laboratory automation accelerating adoption of automated cell shakers in biotechnology?

Automated cell shakers improve consistency, reproducibility, and workflow efficiency while reducing manual intervention, making them increasingly relevant to laboratories standardizing cell culture, microbial growth, sample preparation, and other repetitive processes.

How is the expansion of high-throughput research changing requirements for automated cell shaking systems?

High-throughput workflows require consistent handling of larger sample volumes and coordinated processing, encouraging adoption of cell shakers that integrate with robotic handling, screening, and analytical platforms.

Why do drug development applications account for the largest share of the automated cell shakers market?

Drug development held a 40.83% market share in 2026, reflecting the need for controlled agitation, reproducible cell culture conditions, and reduced manual intervention across pharmaceutical research and development workflows.

What is driving the rapid growth of regenerative medicine applications in the automated cell shakers market?

Regenerative medicine is growing fastest as cell-based therapies and tissue engineering require consistent cell expansion and controlled processing. Automated shakers support reproducibility, reduce manual variability, and improve laboratory workflow efficiency.

What supports North America's leadership in the automated cell shakers market?

North America leads through advanced life sciences infrastructure, strong research activity, and laboratory automation investments supporting consistent workflows across drug discovery, cell culture, and bioprocessing.

Why is Asia Pacific experiencing rapid growth in automated cell shakers?

Expanding biotechnology research, pharmaceutical manufacturing, and laboratory modernization are increasing demand for automated systems that improve throughput, reproducibility, and operational efficiency.

Which companies are driving growth in the automated cell shakers landscape?

Major players in the automated cell shakers market include Thermo Fisher Scientific (USA), Eppendorf (Germany), Sartorius (Germany), INFORS HT (Switzerland), Kuhner Shaker (Switzerland), Benchmark Scientific (USA), Sheldon Manufacturing (USA), Jeio Tech (South Korea), Grant Instruments (UK), Major Science (Taiwan).
Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL
Healthcare & Medical Devices
Research Team Overview

This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team
10+Industry Verticals
100+Countries Analyzed
5-7Days Standard
Delivery
13.8K+Research Reports
Published
On-DemandCustomized Research
Available
6Months Analyst
Support
PDF + XLSReport Deliverables
Trust & Compliance
D&B D-U-N-S
GDPR & CCPA Compliant
ISO 9001 Certified (ISO 9001:2015)
SSL Encryption
Secure Payments
Confidential Handling
Research Intelligence
Primary Research Network
Secondary Sources
Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts
Research Workflow & Quality Assurance
01
Data Collection
Verified information gathered through primary and secondary research.
02
Data Triangulation
Cross-validation using multiple independent data sources.
03
Forecast Modelling
Market estimates developed using historical trends and analytical models.
04
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
05
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
06
Final Publication
Released after successful completion of the internal review process.
Report Coverage
Market Assessment
  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics
🏢 Competitive Intelligence
  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis
🚀 Future Outlook
  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →